|
Ramos-Molina B, Martin MG, Lindberg I. PCSK1 Variants and Human Obesity. Prog Mol Biol Transl Sci. 2016;140:47-74. doi: 10.1016/bs.pmbts.2015.12.001. Epub 2016 Jan 29. Review. PubMed PMID: 27288825; PubMed Central PMCID: PMC6082390.
AÑO: 2016; IF: 2.984
|
27288825
|
Stijnen P, Ramos-Molina B, O'Rahilly S, Creemers JW. PCSK1 Mutations and Human Endocrinopathies: From Obesity to Gastrointestinal Disorders. Endocr Rev. 2016 Aug;37(4):347-71. doi: 10.1210/er.2015-1117. Epub 2016 May 17. Review. PubMed PMID: 27187081.
AÑO: 2016; IF: 15.745
|
|
Stijnen P, Brouwers B, Dirkx E, Ramos-Molina B, Van Lommel L, Schuit F, Thorrez L, Declercq J, Creemers JW. Endoplasmic reticulum-associated degradation of the mouse PC1/3-N222D hypomorph and human PCSK1 mutations contributes to obesity. Int J Obes (Lond). 2016 Jun;40(6):973-81. doi: 10.1038/ijo.2016.3. Epub 2016 Jan 20. PubMed PMID: 26786350.
AÑO: 2016; IF: 5.487
|
|
Yamamoto H, Ramos-Molina B, Lick AN, Prideaux M, Albornoz V, Bonewald L, Lindberg I. Posttranslational processing of FGF23 in osteocytes during the osteoblast to osteocyte transition. Bone. 2016 Mar;84:120-130. doi: 10.1016/j.bone.2015.12.055. Epub 2015 Dec 31. PubMed PMID: 26746780; PubMed Central PMCID: PMC4755901.
AÑO: 2016; IF: 4.14
|
|
Ramos-Molina B, Lick AN, Nasrolahi Shirazi A, Oh D, Tiwari R, El-Sayed NS, Parang K, Lindberg I. Cationic Cell-Penetrating Peptides Are Potent Furin Inhibitors. PLoS One. 2015 Jun 25;10(6):e0130417. doi: 10.1371/journal.pone.0130417. eCollection 2015. PubMed PMID: 26110264; PubMed Central PMCID: PMC4482483.
AÑO: 2015; IF: 2.766
|